Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J A Kanis^{1

2}, C Cooper^{3

4}, R Rizzoli⁵, J-Y Reginster^{6

7}; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF)

Affiliations

¹ Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK. w.j.Pontefract@shef.ac.uk.
² Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia. w.j.Pontefract@shef.ac.uk.
³ MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
⁴ NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.
⁵ University Hospitals and Faculty of Medicine of Geneva, Geneva, Switzerland.
⁶ Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
⁷ Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.

PMID: 32072205
PMCID: PMC7075835
DOI: 10.1007/s00198-020-05303-5

Published Erratum

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J A Kanis et al. Osteoporos Int. 2020 Apr.

. 2020 Apr;31(4):801.

doi: 10.1007/s00198-020-05303-5.

Authors

Affiliations

¹ Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK. w.j.Pontefract@shef.ac.uk.
² Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia. w.j.Pontefract@shef.ac.uk.
³ MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
⁴ NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.
⁵ University Hospitals and Faculty of Medicine of Geneva, Geneva, Switzerland.
⁶ Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
⁷ Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.

PMID: 32072205
PMCID: PMC7075835
DOI: 10.1007/s00198-020-05303-5

Abstract

The article [European guidance for the diagnosis and management of osteoporosis in postmenopausal women], written by [J. A. Kanis], was originally published Online First without Open Access.

PubMed Disclaimer

Erratum for

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). Kanis JA, et al. Osteoporos Int. 2019 Jan;30(1):3-44. doi: 10.1007/s00198-018-4704-5. Epub 2018 Oct 15. Osteoporos Int. 2019. PMID: 30324412 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Affiliations

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources